全球電生理學市場:按產品(測試設備、消融導管、診斷導管)、按適應症(心房顫動、心房撲動、AVNRT、WPW)、按最終用戶(醫院/心臟中心)、按地區- 預測到2028年
市場調查報告書
商品編碼
1421497

全球電生理學市場:按產品(測試設備、消融導管、診斷導管)、按適應症(心房顫動、心房撲動、AVNRT、WPW)、按最終用戶(醫院/心臟中心)、按地區- 預測到2028年

Electrophysiology Market by Product (Laboratory Devices, Ablation Catheters, Diagnostic Catheters), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT, WPW), End-user (Hospitals & Cardiac Centers), and Region - Global Forecast to 2028

出版日期: | 出版商: MarketsandMarkets | 英文 239 Pages | 訂單完成後即時交付

價格
簡介目錄

全球電生理學市場規模預計將從 2023 年的 82 億美元增加到 2028 年的 151 億美元,預測期內複合年成長率為 15.2%。

電生理學市場的預期成長是由技術進步和研究經費增加所推動的。起搏器、植入式心臟植入式心臟整流去顫器(ICD) 和心臟再同步治療 (CRT) 設備等植入式心臟設備的使用頻率不斷增加,促進了電生理市場的成長。

調查範圍
調查年份 2020-2028
基準年 2022年
預測期 2023-2028
單元 金額(十億美元)
部分 按產品、按適應症、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

電生理測試設備將在預測期內達到最高成長。臨床環境中使用的電生理測試設備(例如心臟電生理測試和消融手術)預計將會成長。由於人口老化和治療方法的進步,對更好的臨床電生理工具的需求不斷增加。

許多亞太國家的醫療費用正在上漲,包括中國、印度、日本和韓國。隨著醫療保健基礎設施的發展,電生理設備等先進醫療技術的採用率不斷增加。由於人口老化、生活方式的改變和都市化,亞太地區的心血管疾病正在增加。心臟病的診斷和治療通常依賴電生理程序,增加了對相關設備的需求。

該報告研究了全球電生理學市場,包括按產品、適應症、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 波特五力分析
  • 生態系/市場地圖
  • 價值鏈分析
  • 供應鏈分析
  • 關稅和監管狀況
  • 贖回場景
  • 價格分析
  • 技術分析
  • 專利分析
  • 2023-2024年重大會議和活動
  • 主要相關人員和採購標準
  • 電生理學市場:未滿足的需求

第6章電生理學市場,副產品

  • 介紹
  • 檢驗設備
  • 消融導管
  • 診斷導管
  • 存取裝置
  • 其他

第7章電生理學市場,依指標

  • 介紹
  • 心房顫動
  • 心房撲動
  • 房室結折返性心搏過速
  • 沃爾夫-帕金森-懷特症候群
  • 其他

第 8 章 電生理學市場(依最終使用者)

  • 介紹
  • 醫院和心臟中心
  • 門診手術中心

第 9 章電生理學市場(按地區)

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭形勢

  • 主要參與企業的策略/秘密
  • 收益佔有率分析
  • 市場佔有率分析
  • 企業評價矩陣
  • Start-Ups/小型企業評估矩陣
  • 競爭格局及趨勢
    • 產品上市及核准
    • 出售訊息

第11章 公司簡介

  • 主要參與企業
    • JOHNSON & JOHNSON
    • ABBOTT LABORATORIES
    • MEDTRONIC PLC
    • KONINKLIJKE PHILIPS NV
    • GE HEALTHCARE
    • BOSTON SCIENTIFIC CORPORATION
    • JAPAN LIFELINE
    • STEREOTAXIS
    • MICROPORT SCIENTIFIC CORPORATION
    • BIOTRONIK
    • ACUTUS MEDICAL
    • EP SOLUTIONS SA
    • APN HEALTH, LLC
    • OSYPKA
    • EPMAP-SYSTEM GMBH & CO. KG
  • 其他公司
    • CATHRX LTD.
    • MERIT MEDICAL SYSTEMS
    • COOK MEDICAL
    • CATHVISION
    • TZ MEDICAL
    • TELEFLEX
    • LEPU MEDICAL TECHNOLOGY
    • CARDIOFOCUS
    • SCHWARZER CARDIOTEK
    • IMRICOR MEDICAL SYSTEMS

第12章附錄

簡介目錄
Product Code: MD 3273

Report Description

The global Electrophysiology market is projected to reach USD 15.1 billion by 2028 from USD 8.2 billion in 2023, growing at a CAGR of 15.2% during the forecast period. The projected increase in market growth for the Electrophysiology market is seen due to technological advancements and Increased research funding. The increasing frequency of implantable cardiac devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization treatment (CRT) devices contributes to the electrophysiology market's growth.

Scope of the Report
Years Considered for the Study2020-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsProduct, Indication, End User and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa

"The electrophysiology laboratory devices segment to register highest growth over the forecast period of 2023-2028."

Based on the product, the Electrophysiology market is segmented into electrophysiology laboratory devices, electrophysiology ablation catheters,electrophysiology diagnostic catheters, EP access products, and other devices. Electrophysiology laboratory devices is to witness the highest growth during the forecast period. Electrophysiology equipment used in clinical settings, such as cardiac electrophysiology investigations and ablation procedures, has been expected to grow. The need for better clinical electrophysiological tools is fueled by ageing populations and advancements in treatment modalities.

"Asia Pacific to register highest CAGR in the market during the forecast period."

For the forecasting period 2023-2028, the APAC region is expected to register a significant growth rate in the market during the forecast period. Asia Pacific comprises India, China, Japan, Australia, South Korea, and RoAPAC. The Asia-Pacific (APAC) region has witnessed a significant increase in the market growth rate for the electrophysiology market. There are several drivers that contributed to this growth:

The cost of healthcare has been rising in many APAC nations, including China, India, Japan, and South Korea. Advanced medical technology, like electrophysiological devices, are being adopted at a higher rate as the healthcare infrastructure gets better. APAC is seeing an increase in cardiovascular disorders due to ageing populations, changing lifestyles, and urbanisation. The diagnosis and treatment of cardiac disorders frequently depend on electrophysiology procedures, which raises the need for associated devices.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
  • By Designation: C-level-27%, Director-level-18%, and Others-55%
  • By Region: North America-50%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%

Research Coverage

  • The report studies the Electrophysiology market based on Product, Indication, End User and Region.
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
  • The report studies micro markets concerning their growth trends, prospects, and contributions to the global electrophysiology market.
  • The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants/smaller firms in this market with investment evaluation viability within the Electrophysiology market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing application, end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, growth catalysts, challenges, and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

  • Analysis of key drivers (Technology advancements) (Growing investments,funds), opportunities (Expansion of key players in emerging countries, Rising healthcare expenditure across developing countries), and challenges (Availability of alternative technology) influencing the growth of the Electrophysiology market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the electrophysiology market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the Electrophysiology market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electrophysiology market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Johnson & Johnson (US), Abbott Laboratories (US), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Boston Scientific (US) among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
    • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 1 RESEARCH DESIGN
    • FIGURE 2 ELECTROPHYSIOLOGY MARKET: MARKET GROWTH IMPACT ANALYSIS
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Breakdown of primaries
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION
    • 2.2.1 END USER-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION
    • FIGURE 6 BOTTOM-UP APPROACH
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 LIMITATIONS
  • 2.5 RISK ASSESSMENT
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 ELECTROPHYSIOLOGY MARKET: RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 ELECTROPHYSIOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD (2023-2028)

4 PREMIUM INSIGHTS

  • 4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW
    • FIGURE 13 TECHNOLOGICAL ADVANCEMENTS TO DRIVE GLOBAL ELECTROPHYSIOLOGY MARKET GROWTH
  • 4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION
    • FIGURE 14 ATRIAL FIBRILLATION SEGMENT DOMINATED ELECTROPHYSIOLOGY MARKET IN 2022
  • 4.3 ELECTROPHYSIOLOGY MARKET: GEOGRAPHICAL SNAPSHOT
    • FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2023-2028)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Technological advancements
        • 5.2.1.1.1 Rising use of noninvasive cardiac mapping
        • 5.2.1.1.2 Increased use of improved intracardiac ablation systems
        • 5.2.1.1.3 Increased use of MRI-guided ablation procedures
        • 5.2.1.1.4 Growing level of ultrasound guidance in EP labs
      • 5.2.1.2 Rising number of new entrants
      • 5.2.1.3 Growing investments, funds, and grants for cardiac surgeries and electrophysiology
      • 5.2.1.4 Increasing disease incidence and procedural volume
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High product cost and inadequate reimbursement
      • 5.2.2.2 Unfavorable healthcare reforms in US
      • 5.2.2.3 Cost-intensive data requirements for product launches and availability of alternative technologies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing device reuse and reprocessing
      • 5.2.4.2 Lack of skilled and experienced personnel
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 ELECTROPHYSIOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 ECOSYSTEM/MARKET MAP
    • FIGURE 17 ELECTROPHYSIOLOGY MARKET: ECOSYSTEM/MARKET MAP
  • 5.5 VALUE CHAIN ANALYSIS
    • 5.5.1 RESEARCH & DEVELOPMENT
    • 5.5.2 PROCUREMENT AND PRODUCT DEVELOPMENT
    • 5.5.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
    • FIGURE 18 ELECTROPHYSIOLOGY MARKET: VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
    • 5.6.1 PROMINENT COMPANIES
    • 5.6.2 END USERS
    • FIGURE 19 ELECTROPHYSIOLOGY MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 TARIFF & REGULATORY LANDSCAPE
    • 5.7.1 NORTH AMERICA
      • 5.7.1.1 US
    • TABLE 3 CLASSIFICATION OF MEDICAL DEVICES BY US FDA (2022)
    • TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2022)
      • 5.7.1.2 Canada
    • TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS (2022)
    • 5.7.2 EUROPE
    • 5.7.3 ASIA PACIFIC
      • 5.7.3.1 India
      • 5.7.3.2 China
    • TABLE 6 CHINA: NMPA CLASSIFICATION OF MEDICAL DEVICES (2022)
      • 5.7.3.3 Japan
    • TABLE 7 JAPAN: PMDA CLASSIFICATION OF MEDICAL DEVICES (2022)
    • 5.7.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 REIMBURSEMENT SCENARIO
    • TABLE 12 ELECTROPHYSIOLOGY MARKET: CPT CODES
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE PRICE OF ELECTROPHYSIOLOGY PRODUCTS, 2022 (USD)
  • 5.10 TECHNOLOGY ANALYSIS
    • TABLE 13 ELECTROPHYSIOLOGY MARKET: PROMINENT PRODUCT LAUNCHES (JANUARY 2019-DECEMBER 2023)
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENTS GRANTED FOR ELECTROPHYSIOLOGY
    • FIGURE 20 ELECTROPHYSIOLOGY MARKET: TOP 10 PATENT APPLICANTS
    • FIGURE 21 ELECTROPHYSIOLOGY MARKET: TOP 10 PATENT OWNERS
  • 5.12 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 14 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY END USER
    • FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
    • TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
    • 5.13.2 BUYING CRITERIA
    • FIGURE 23 KEY BUYING CRITERIA, BY END USER
    • TABLE 16 KEY BUYING CRITERIA, BY STAKEHOLDER
  • 5.14 ELECTROPHYSIOLOGY MARKET: UNMET NEEDS

6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 17 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 LABORATORY DEVICES
    • TABLE 18 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 19 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 20 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 21 ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1 3D MAPPING SYSTEMS
      • 6.2.1.1 Development of alternative technologies to hinder market growth
    • TABLE 22 3D MAPPING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 RECORDING SYSTEMS
      • 6.2.2.1 Increasing public-private funding to support growth
    • TABLE 23 RECORDING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.3 RF ABLATION SYSTEMS
      • 6.2.3.1 Rising number of RF ablation procedures to drive market
    • TABLE 24 RF ABLATION SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.4 ICE ULTRASOUND IMAGING SYSTEMS
      • 6.2.4.1 Advantages of ICE ultrasound imaging to drive market
    • TABLE 25 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.5 X-RAY SYSTEMS
      • 6.2.5.1 Growing availability of magnetic navigation systems to hamper market growth
    • TABLE 26 X-RAY SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.6 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS
      • 6.2.6.1 Favorable reimbursement scenario to drive market
    • TABLE 27 REMOTE MAGNETIC & ROBOTIC NAVIGATION SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 ABLATION CATHETERS
    • TABLE 28 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 29 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 30 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 31 ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.1 CRYOABLATION CATHETERS
      • 6.3.1.1 Significant therapeutic advantages to drive market
    • TABLE 32 CRYOABLATION CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.2 RF ABLATION CATHETERS
      • 6.3.2.1 Technological advancements to drive market
    • TABLE 33 RF ABLATION CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.3 MWA SYSTEMS
      • 6.3.3.1 Advantages of microwave ablation over RF to support growth
    • TABLE 34 COMPARISON OF MICROWAVE AND RADIOFREQUENCY ABLATION
    • TABLE 35 MWA SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.4 LASER ABLATION SYSTEMS
      • 6.3.4.1 Technologically advanced products to drive market
    • TABLE 36 LASER ABLATION SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4 DIAGNOSTIC CATHETERS
    • TABLE 37 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 38 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 39 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 40 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.4.1 CONVENTIONAL DIAGNOSTIC CATHETERS
      • 6.4.1.1 Increasing demand in emerging markets to support market growth
    • TABLE 41 CONVENTIONAL DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.4.2 ADVANCED DIAGNOSTIC CATHETERS
      • 6.4.2.1 Advantages over conventional catheters to drive market
    • TABLE 42 ADVANCED DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.4.3 ULTRASOUND DIAGNOSTIC CATHETERS
      • 6.4.3.1 Increased demand due to the rising use of ICE ultrasound imaging to drive market
    • TABLE 43 ULTRASOUND DIAGNOSTIC CATHETERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.5 ACCESS DEVICES
    • 6.5.1 LAUNCH OF ADVANCED PRODUCTS TO DRIVE MARKET
    • TABLE 44 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 45 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 46 ELECTROPHYSIOLOGY ACCESS DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.6 OTHER PRODUCTS
    • TABLE 47 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 48 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 49 OTHER ELECTROPHYSIOLOGY PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)

7 ELECTROPHYSIOLOGY MARKET, BY INDICATION

  • 7.1 INTRODUCTION
    • TABLE 50 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • 7.2 ATRIAL FIBRILLATION
    • 7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET
    • TABLE 51 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 ATRIAL FLUTTER
    • 7.3.1 HIGH SUCCESS RATE OF RF CATHETER ABLATION TO DRIVE MARKET
    • TABLE 52 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA
    • 7.4.1 EFFICACY OF ELECTROPHYSIOLOGY DEVICES IN AVNRT APPLICATIONS TO DRIVE MARKET
    • TABLE 53 ELECTROPHYSIOLOGY MARKET FOR AVNRT, BY REGION, 2021-2028 (USD MILLION)
  • 7.5 WOLFF-PARKINSON-WHITE SYNDROME
    • 7.5.1 GROWING PREFERENCE FOR RF ABLATION TREATMENT OVER SURGERY TO DRIVE MARKET
    • TABLE 54 ELECTROPHYSIOLOGY MARKET FOR WPW SYNDROME, BY REGION, 2021-2028 (USD MILLION)
  • 7.6 OTHER INDICATIONS
    • TABLE 55 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2021-2028 (USD MILLION)

8 ELECTROPHYSIOLOGY MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 56 ELECTROPHYSIOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS & CARDIAC CENTERS
    • 8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE END-USER MARKET
    • TABLE 57 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 AMBULATORY SURGERY CENTERS
    • 8.3.1 INCREASING NUMBER OF CENTERS TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES
    • TABLE 58 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2028 (USD MILLION)

9 ELECTROPHYSIOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 59 ELECTROPHYSIOLOGY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 24 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • TABLE 60 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 NORTH AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 64 NORTH AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 66 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 Technological advancements to drive market growth
    • TABLE 67 US: CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES
    • TABLE 68 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 69 US: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 70 US: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 71 US: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Growing government funding for research to support market growth
    • TABLE 72 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
    • TABLE 73 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 74 CANADA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 CANADA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 76 CANADA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 EUROPE: RECESSION IMPACT
    • TABLE 77 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 80 EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 81 EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 82 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 83 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market
    • TABLE 84 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 85 GERMANY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 86 GERMANY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 87 GERMANY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Growing geriatric population to drive market
    • TABLE 88 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 89 UK: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 UK: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 UK: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.4 FRANCE
      • 9.3.4.1 Increasing incidence of heart failure to support market growth
    • TABLE 92 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 93 FRANCE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 FRANCE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 FRANCE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Rising incidence of CVD to drive electrophysiology device adoption
    • TABLE 96 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 97 ITALY: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 ITALY: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 ITALY: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Growing number of cardiac ablation procedures to drive market growth
    • TABLE 100 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 101 SPAIN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 SPAIN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 SPAIN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 104 REST OF EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 105 REST OF EUROPE: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 REST OF EUROPE: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 107 REST OF EUROPE: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 25 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT
    • TABLE 108 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Favorable reimbursement scenario to support market growth
    • TABLE 115 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 116 JAPAN: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 JAPAN: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 JAPAN: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.3 CHINA
      • 9.4.3.1 Growing geriatric population to drive market
    • TABLE 119 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 120 CHINA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 CHINA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 122 CHINA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing healthcare initiatives by government to drive market growth
    • TABLE 123 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 124 INDIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 INDIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 INDIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing target disease burden to support market growth
    • TABLE 127 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 128 AUSTRALIA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 129 AUSTRALIA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 AUSTRALIA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Supportive government initiatives to drive market growth
    • TABLE 131 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 132 SOUTH KOREA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 133 SOUTH KOREA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 134 SOUTH KOREA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.7 REST OF ASIA PACIFIC
    • TABLE 135 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 136 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 138 REST OF ASIA PACIFIC: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 139 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 140 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 141 LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 144 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 145 LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.2 BRAZIL
      • 9.5.2.1 Modernization of healthcare facilities to drive market growth
    • TABLE 146 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 147 BRAZIL: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 BRAZIL: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 BRAZIL: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.5.3 MEXICO
      • 9.5.3.1 Favorable investment scenario for medical device manufacturers to drive market
    • TABLE 150 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 151 MEXICO: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 MEXICO: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 MEXICO: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 154 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 155 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF LATIN AMERICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 RISING POPULATION AND DISEASE INCIDENCE TO ATTRACT MARKET PLAYERS
    • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 158 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 159 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • TABLE 163 MIDDLE EAST & AFRICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 26 OVERVIEW OF STRATEGIES DEPLOYED BY ELECTROPHYSIOLOGY MARKET PLAYERS
  • 10.2 REVENUE SHARE ANALYSIS
    • FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS, 2020-2022
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 28 ELECTROPHYSIOLOGY MARKET SHARE ANALYSIS, 2022
    • TABLE 164 ELECTROPHYSIOLOGY MARKET: DEGREE OF COMPETITION
  • 10.4 COMPANY EVALUATION MATRIX
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • FIGURE 29 ELECTROPHYSIOLOGY MARKET: COMPETITIVE EVALUATION MATRIX, 2022
    • 10.4.5 COMPANY FOOTPRINT
    • TABLE 165 PRODUCT FOOTPRINT
    • TABLE 166 END-USER FOOTPRINT
    • TABLE 167 REGIONAL FOOTPRINT
  • 10.5 START-UP/SME EVALUATION MATRIX
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 RESPONSIVE COMPANIES
    • 10.5.3 DYNAMIC COMPANIES
    • 10.5.4 STARTING BLOCKS
    • FIGURE 30 ELECTROPHYSIOLOGY MARKET: START-UP/SME EVALUATION MATRIX, 2022
    • 10.5.5 COMPETITIVE BENCHMARKING
    • TABLE 168 ELECTROPHYSIOLOGY MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 169 ELECTROPHYSIOLOGY MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • 10.6 COMPETITIVE SCENARIO AND TRENDS
    • 10.6.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 170 ELECTROPHYSIOLOGY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2019-DECEMBER 2023
    • 10.6.2 DEALS
    • TABLE 171 ELECTROPHYSIOLOGY MARKET: DEALS, JANUARY 2019-DECEMBER 2023

11 COMPANY PROFILES

  • (Business overview, Products/Solutions/Services offered, Recent developments & MnM View)**
  • 11.1 KEY PLAYERS
    • 11.1.1 JOHNSON & JOHNSON
    • TABLE 172 JOHNSON & JOHNSON: COMPANY OVERVIEW
    • FIGURE 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
    • 11.1.2 ABBOTT LABORATORIES
    • TABLE 173 ABBOTT LABORATORIES: COMPANY OVERVIEW
    • FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 11.1.3 MEDTRONIC PLC
    • TABLE 174 MEDTRONIC PLC: COMPANY OVERVIEW
    • FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
    • 11.1.4 KONINKLIJKE PHILIPS N.V.
    • TABLE 175 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 11.1.5 GE HEALTHCARE
    • TABLE 176 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 11.1.6 BOSTON SCIENTIFIC CORPORATION
    • TABLE 177 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
    • FIGURE 36 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 11.1.7 JAPAN LIFELINE
    • TABLE 178 JAPAN LIFELINE: COMPANY OVERVIEW
    • FIGURE 37 JAPAN LIFELINE: COMPANY SNAPSHOT (2022)
    • 11.1.8 STEREOTAXIS
    • TABLE 179 STEREOTAXIS: COMPANY OVERVIEW
    • FIGURE 38 STEREOTAXIS: COMPANY SNAPSHOT (2022)
    • 11.1.9 MICROPORT SCIENTIFIC CORPORATION
    • TABLE 180 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW
    • FIGURE 39 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.10 BIOTRONIK
    • TABLE 181 BIOTRONIK: COMPANY OVERVIEW
    • 11.1.11 ACUTUS MEDICAL
    • TABLE 182 ACUTUS MEDICAL: COMPANY OVERVIEW
    • 11.1.12 EP SOLUTIONS SA
    • TABLE 183 EP SOLUTIONS SA: COMPANY OVERVIEW
    • 11.1.13 APN HEALTH, LLC
    • TABLE 184 APN HEALTH: COMPANY OVERVIEW
    • 11.1.14 OSYPKA
    • TABLE 185 OSYPKA: COMPANY OVERVIEW
    • 11.1.15 EPMAP-SYSTEM GMBH & CO. KG
    • TABLE 186 EPMAP-SYSTEM GMBH & CO. KG: COMPANY OVERVIEW
  • *Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
  • 11.2 OTHER PLAYERS
    • 11.2.1 CATHRX LTD.
    • 11.2.2 MERIT MEDICAL SYSTEMS
    • 11.2.3 COOK MEDICAL
    • 11.2.4 CATHVISION
    • 11.2.5 TZ MEDICAL
    • 11.2.6 TELEFLEX
    • 11.2.7 LEPU MEDICAL TECHNOLOGY
    • 11.2.8 CARDIOFOCUS
    • 11.2.9 SCHWARZER CARDIOTEK
    • 11.2.10 IMRICOR MEDICAL SYSTEMS

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS